© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Researchers compared data on more than 9,000 people with HIV who took either version of tenofovir.
Stop by during the Oklahoma City Pride Festival on June 22 for an HIV Test, a visit with a doc and a script for PrEP.
Nearly $200 million of the pledge will go to DREAMS programs in Africa and the Caribbean.
The proposal allows pharmacies to dispense a first-time 30-day supply of the HIV prevention pill without a script.
In the form of direct quotes from the participants
Truvada and Descovy are both highly effective and generally safe options for HIV prevention.
An early trial of Gilead’s HIV capsid inhibitor supports three-month dosing.
A photo journal of the #PrEP4All activists at the House hearings on Gilead, PrEP, and Truvada pricing.
Gilead Sciences CEO defends high drug prices and claims the CDC does not own the patent to HIV prevention pill Truvada.
Pharma giants made agreements to keep prices high and block competition for generics, the civil lawsuit alleges.
Do not fall for Gilead’s vile marketing ploy.
The Truvada manufacturer’s agreement with the Trump Administration is “a tremendous step toward ending the epidemic.”
This will provide free PrEP to as many as 200,000 uninsured Americans until 2030.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
